Literature DB >> 28427585

Ticagrelor Versus Clopidogrel on Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention.

Eun Kyoung Kim, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Jin-Ho Choi, Seung-Hyuk Choi, Woo Jung Chun, Yeon Hyeon Choe, Hyeon-Cheol Gwon, Joo-Yong Hahn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28427585     DOI: 10.1016/j.jacc.2017.02.034

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  Effects of Ticagrelor on Myocardial Infarct Size.

Authors:  Joo-Yong Hahn
Journal:  Korean Circ J       Date:  2017-09-11       Impact factor: 3.243

2.  Translation of experimental cardioprotective capability of P2Y12 inhibitors into clinical outcome in patients with ST-elevation myocardial infarction.

Authors:  Marie V Hjortbak; Kevin K W Olesen; Jacob M Seefeldt; Thomas R Lassen; Rebekka V Jensen; Alexander Perkins; Matthew Dodd; Tim Clayton; Derek Yellon; Derek J Hausenloy; Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2021-05-26       Impact factor: 17.165

3.  Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel.

Authors:  Stylianos Petousis; Michalis Hamilos; Konstantinos Pagonidis; Panos Vardas; Georgios Lazopoulos; Ioannis Anastasiou; Evangelos Zacharis; George Kochiadakis; Emmanouil Skalidis
Journal:  BMC Cardiovasc Disord       Date:  2022-07-02       Impact factor: 2.174

4.  Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial.

Authors:  Kyungil Park; Young-Rak Cho; Jong-Sung Park; Tae-Ho Park; Moo-Hyun Kim; Young-Dae Kim
Journal:  J Cardiovasc Transl Res       Date:  2018-01-17       Impact factor: 4.132

5.  Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor?

Authors:  Nil Ozyuncu; Hüseyin Göksülük; Turkan Seda Tan; Kerim Esenboga; Yusuf Atmaca; Çetin Erol
Journal:  Anatol J Cardiol       Date:  2020-08       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.